Sign in
BGLC Stock Price, Chart, Stats & News
BioNexus Gene Lab Corp.
Save
BioNexus Gene Lab Corp. (BGLC) does not currently pay a dividend.
2.95M
Market cap
–
Current P/E
–
Forward P/E
BGLC chart
Fundamentals
Gross margin | 14.77% |
Operating margin | -24.81% |
Pretax margin | -25.05% |
Net margin | -24.27% |
Effective tax rate | 3.11% |
ROA | -30.14% |
ROE | -30.19% |
D/E | 0.03x |
Interest coverage ratio | -150.54x |
BGLC valuation
P/E | – |
P/S | 0.45x |
P/B | 0.62x |
P/CF | -1.48x |
P/FCF | -1.46x |
P/OCF | -1.48x |
PEG | -0.08x |
EV multiple | -3.22x |
About
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia.
Similar securities
Based on sector and market capitalization
Report issue